Country Reports — Market Intelligence by Geography

Markets NXT — A Montclaire & Stein Venture

A Century of Global Intelligence Behind Every Report

Markets NXT builds on a legacy dating to the early 1900s, when economists Edgar Montclaire and Johann Stein began advising enterprises across Europe and North America on industrial expansion and globalization. Over more than a century, Montclaire & Stein accumulated institutional knowledge spanning economic intelligence and market dynamics across geographies — forming the analytical foundation behind every report we publish today.

Why Country-Level Intelligence Matters

Global markets are not uniform. Regulatory environments, consumer behavior, industrial composition, and competitive dynamics differ significantly by country. Country-specific research helps businesses:

  • Accurately size and forecast a market within a defined geography
  • Understand local demand drivers, supply chains, and competition
  • Navigate country-specific regulatory and policy frameworks
  • Identify entry points, opportunities, and risk factors at a national level

What Our Country Reports Cover

Each report delivers institutional-grade intelligence across: market sizing and forecasting, industry segmentation, competitive landscape, regulatory environment, macroeconomic context, and strategic recommendations — all grounded in conservative, multi-source validated methodology.

Institutional Rigour at the Most Competitive Pricing

Markets NXT offers country-specific research at the most competitive pricing in the industry, without compromising analytical standards. Our reports serve growth-stage businesses, investment firms, and consulting teams that need board-level intelligence without enterprise-level costs.

Explore Reports by Country

Browse and filter below to find market research reports for the country of your interest. Coverage spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Showing 1 - 10 of 67 reports

U.S. Brugada Syndrome Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Brugada Syndrome Market Market Size 2024: USD 312.4 Million Market Size 2032: USD 587.9 Million CAGR: 8.2% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — ICD Implantation Drives Revenue: Implantable cardioverter-defibrillator implantation accounts for … Read More
Published September 2026

U.S. Mycoplasma Testing Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Mycoplasma Testing Market Size 2024: USD 1.12 billion Market Size 2032: USD 2.31 billion CAGR: 9.4% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — PCR Dominance Reshaping Compliance: Polymerase chain reaction-based mycoplasma detection now … Read More
Published September 2026

U.S. Microspheres Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Microspheres Market Size 2024: USD 4.2 Billion Market Size 2032: USD 7.9 Billion CAGR: 8.2% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — 3M's Hollow Glass Dominance: 3M controls over 30% of hollow glass … Read More
Published September 2026

U.S. High Throughput Screening Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 4.2 Billion Market Size 2032: USD 8.7 Billion CAGR: 9.5% Market Definition: The U.S. high throughput screening market encompasses automated laboratory systems, reagents, assay kits, and software platforms used to rapidly test large compound libraries for drug discovery, genomics, … Read More
Published September 2026

U.S. Alpha Thalassemia Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Alpha Thalassemia Market Size 2024: USD 412 million Market Size 2032: USD 1.94 billion CAGR: 21.4% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Gene Therapy Pipeline Dominance: Silence Therapeutics and Beam Therapeutics have … Read More
Published September 2026

U.S. ADME Toxicology Testing Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 3.2 Billion Market Size 2032: USD 6.1 Billion CAGR: 8.4% Market Definition: The U.S. ADME toxicology testing market encompasses in vitro, in vivo, and in silico assays that evaluate absorption, distribution, metabolism, excretion, and toxicological properties of drug candidates. … Read More
Published September 2026

U.S. Active B12 Test Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 312.4 million Market Size 2032: USD 598.7 million CAGR: 8.4% Market Definition: The U.S. active B12 test market encompasses diagnostic assays measuring holotranscobalamin (holoTC), the biologically available fraction of vitamin B12, used clinically to detect early functional B12 deficiency … Read More
Published September 2026

U.S. Evans Syndrome Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 412.6 Million Market Size 2032: USD 718.4 Million CAGR: 7.2% Market Definition: The U.S. Evans Syndrome market encompasses diagnostics, therapeutics, and disease management products for a rare autoimmune condition characterized by simultaneous or sequential autoimmune hemolytic anemia and immune … Read More
Published September 2026

U.S. Cell Cycle Analysis Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Cell Cycle Analysis Market Size 2024: USD 1.42 billion Market Size 2032: USD 2.89 billion CAGR: 9.3% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Flow Cytometry Dominates Revenue: BD Biosciences controls an estimated … Read More
Published September 2026

U.S. Cell Banking Outsourcing Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Cell Banking Outsourcing Market Size 2024: USD 412.6 million Market Size 2032: USD 1,184.3 million CAGR: 14.1% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — FDA Guidance Reshaping Contracts: The FDA's 2024 finalized guidance … Read More
Published September 2026
First Prev 1 2 3 Next Last